Dr. Dima is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000
Education & Training
Tufts Medical CenterResidency, Internal Medicine, 2018 - 2021
University of AthensClass of 2017
Certifications & Licensure
OH State Medical License 2021 - 2025
WA State Medical License 2024 - 2025
MA State Medical License 2018 - 2021- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 35 citationsReal-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.Christopher J Ferreri, Michelle A T Hildebrandt, Hamza Hashmi, Leyla O Shune, Joseph P McGuirk
Blood Cancer Journal. 2023-08-09 - 4 citationsTiming of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma.William Wesson, Danai Dima, Nahid Suleman, Md Saiful Islam Saif, Carine Tabak
Transplantation and Cellular Therapy. 2024-09-01 - 90 citationsIdecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.Doris K Hansen, Surbhi Sidana, Lauren C Peres, Christelle Colin Leitzinger, Leyla Shune
Journal of Clinical Oncology. 2023-04-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
